Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 1
2004 4
2005 3
2006 4
2007 2
2008 1
2009 7
2010 2
2011 5
2012 6
2013 5
2014 2
2015 4
2016 9
2017 5
2018 6
2019 5
2020 8
2021 9
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Results by year
Filters applied: . Clear all
Page 1
CD8+ T Cell Exhaustion in Cancer.
Dolina JS, Van Braeckel-Budimir N, Thomas GD, Salek-Ardakani S. Dolina JS, et al. Among authors: salek ardakani s. Front Immunol. 2021 Jul 20;12:715234. doi: 10.3389/fimmu.2021.715234. eCollection 2021. Front Immunol. 2021. PMID: 34354714 Free PMC article. Review.
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG. Freeman-Cook K, et al. Among authors: salek ardakani s. Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13. Cancer Cell. 2021. PMID: 34520734
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.
Chen SH, Dominik PK, Stanfield J, Ding S, Yang W, Kurd N, Llewellyn R, Heyen J, Wang C, Melton Z, Van Blarcom T, Lindquist KC, Chaparro-Riggers J, Salek-Ardakani S. Chen SH, et al. Among authors: salek ardakani s. J Immunother Cancer. 2021 Oct;9(10):e003464. doi: 10.1136/jitc-2021-003464. J Immunother Cancer. 2021. PMID: 34599020 Free PMC article.
Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab.
Chin SM, Kimberlin CR, Roe-Zurz Z, Zhang P, Xu A, Liao-Chan S, Sen D, Nager AR, Oakdale NS, Brown C, Wang F, Yang Y, Lindquist K, Yeung YA, Salek-Ardakani S, Chaparro-Riggers J. Chin SM, et al. Among authors: salek ardakani s. Nat Commun. 2018 Nov 8;9(1):4679. doi: 10.1038/s41467-018-07136-7. Nat Commun. 2018. PMID: 30410017 Free PMC article.
Editorial: Follicular Helper T Cells in Immunity and Autoimmunity.
Cicalese MP, Salek-Ardakani S, Fousteri G. Cicalese MP, et al. Among authors: salek ardakani s. Front Immunol. 2020 May 29;11:1042. doi: 10.3389/fimmu.2020.01042. eCollection 2020. Front Immunol. 2020. PMID: 32670272 Free PMC article. No abstract available.
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics.
Davda J, Declerck P, Hu-Lieskovan S, Hickling TP, Jacobs IA, Chou J, Salek-Ardakani S, Kraynov E. Davda J, et al. Among authors: salek ardakani s. J Immunother Cancer. 2019 Apr 15;7(1):105. doi: 10.1186/s40425-019-0586-0. J Immunother Cancer. 2019. PMID: 30992085 Free PMC article. Review.
CD40 agonist-induced IL-12p40 potentiates hepatotoxicity.
Bonnans C, Thomas G, He W, Jung B, Chen W, Liao M, Heyen J, Buetow B, Pillai S, Matsumoto D, Chaparro-Riggers J, Salek-Ardakani S, Qu Y. Bonnans C, et al. Among authors: salek ardakani s. J Immunother Cancer. 2020 May;8(1):e000624. doi: 10.1136/jitc-2020-000624. J Immunother Cancer. 2020. PMID: 32474414 Free PMC article.
Macrophage adaptation in airway inflammatory resolution.
Kaur M, Bell T, Salek-Ardakani S, Hussell T. Kaur M, et al. Among authors: salek ardakani s. Eur Respir Rev. 2015 Sep;24(137):510-5. doi: 10.1183/16000617.0030-2015. Eur Respir Rev. 2015. PMID: 26324813 Free article. Review.
82 results